康臣药业（01681）于2026年6月26日公告显示，当日公司在香港联交所场内回购普通股15.6万股，占回购前已发行股份（不包括库存股份）约0.0186%。回购价格区间介乎每股12.48港元至12.62港元，合计支付约195.81万港元。完成后，公司已发行股份（不包括库存股份）由8.39268111亿股减少至8.39112111亿股，库存股份数量增至243.5万股，合计已发行股本仍为8.41547111亿股。
公告同时披露，此次股票回购依据2026年5月26日通过的回购授权进行，该授权可回购股票总数为8412.0311万股。截至目前，公司已根据该授权累计回购209.1万股，占授权通过当日已发行股本约2.4857%。公司表示，本次回购已遵守香港联合交易所有限公司证券上市规则及相关法律规定。该公告由公司秘书高海恩签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.